Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Holden Comprehensive Cancer Center
Information provided by (Responsible Party):
John M. Buatti, University of Iowa
ClinicalTrials.gov Identifier:
NCT01065844
First received: February 8, 2010
Last updated: December 4, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)